Abstract:Nervous necrosis virus (NNV) capsid protein plays an important role in producing viral particles without any genetic elements. Thus, NNV is a promising candidate for vaccine development and is widely used for constructing vaccines, including DNA, recombinant proteins, and virus-like particles (VLPs). Our study aimed to investigate the potential of NNV capsid protein (NNV) and NNV capsid protein fused to enhanced green fluorescent protein (NNV-EGFP) through VLP formation and whether their application can induce specific antibody responses against certain antigens. We focused on producing DNA and recombinant protein vaccines consisting of the genes for NNV, EGFP, and NNV-EGFP. The approach using NNV-EGFP allowed NNV to act as a carrier or inducer while EGFP was incorporated as part of the capsid protein, thereby enhancing the immune response. In vitro studies demonstrated that all DNA vaccines expressed in HINAE cells resulted in varying protein expression levels, with particularly low levels observed for pNNV and pNNV-EGFP. Consequently, structural proteins derived from HINAE cells could not be observed using transmission electron microscopy (TEM). In contrast, recombinant proteins of NNV and NNV-EGFP were expressed through the Escherichia coli expression system. TEM revealed that rNNV was assembled into VLPs with an approximate size of 30 nm, whereas rNNV-EGFP presented particles ranging from 10 nm to 50 nm in size. For the vaccination test, DNA vaccination marginally induced specific antibody responses in Japanese flounder compared to unvaccinated fish. Meanwhile, NNV and NNV-EGFP recombinant vaccines enhanced a greater anti-NNV antibody response than the others, whereas antibody responses against EGFP were also marginal. These results indicate that NNV capsid protein-based antigens, presenting as particles, play an important role in eliciting a specific anti-NNV antibody response and have the potential to improve fish immune responses.

The Biological Character of Capsid Protein Expressed in Insect Cells from Fish Viral Nervous Necrosis Virus

Research Article an Improved Bac-to-Bac/BmNPV Technology Expressing Envelope E2 Glycoprotein of Classical Swine Fever Virus (CSFV) in the Silkworm, Bombyx Mori

Expression of Vp2e and Vp3 Genes from Marine Birnavirus (MABV) in Insect Cells

Development of Tobacco necrosis virus A as a vector for efficient and stable expression of FMDV VP1 peptides.

Expression of Cysteine Protease Gene in Bm-BmNPV Expression System

Construction of Cell Line Stably Expressing IBDV VP2 Protein Mutants

Immobilization of Foreign Protein into BmNPV Polyhedra Through Fusion with Partial Polyhedrin Fragment

Immobilization of Foreign Protein into Polyhedra of Bombyx Mori Nucleopolyhedrovirus (Bmnpv)

Application of nervous necrosis virus capsid protein-based antigen-presenting particles for vaccine development

Prokaryotic Expression of Structural Domains of the Newcastle Disease Virus Hemagglutinin-Neuraminidase

Immobilization of Foreign Protein in BmNPV Polyhedra by Fusion Expression with Partial Polyhedrin Fragments

An Observation on Immobilization of Foreign Protein in Polyhedra of BmNPV

Cloning and Expression of the Nucleoprotein Gene of Era Rabies Virus

Expression of E2 Protein of Classical Swine Fever Virus Shimen Strain Using Baculovrius Expression System

Construction of a Host Range-Expanded Hybrid Baculovirus of BmNPV and AcNPV, and Knockout of Cysteinase Gene for More Efficient Expression

Expression of Nucleoprotein of Rabies Virus in Bac-To-Bac/AcMNPV Baculovirus Expression System

In Vivo Characterization of Chimeric PCV DNA Clones Containing Heterogeneous Capsid Protein Nuclear Localization Signals (NLS).

A novel application of baculovirus in mammalian gene therapy]

Cell Surface Display of Rabies Virus Glycoprotein by Using Ice Nucleation Protein

Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly.

Mass Production of Virus-Like Particles Using Chloroplast Genetic Engineering for Highly Immunogenic Oral Vaccine Against Fish Disease